LIMN

2.51010.68%
CK

Chris Kim

CEO, Chairman & President

Mr. Chris Kim, JD, LLM serves as Chief Executive Officer and Director of Liminatus Pharma, Inc. since November 23, 2022 and serves as its Chairman & President and served as its Treasurer & Secretary. He serves as a Director of Coagentus Pharma, LLC. Mr. Kim is of Counsel for DeHeng Law Office NY, the largest law firm in China. He has extensive international experience that has involved transactions on behalf of companies in Asia, Europe as well as North America including, but not limited to, Wal-Mart, IBM, Sony, GE, Toyota, Deutsche Bank, UBS, Samsung, Korea Telecom (with British Telecom, AT&T and Sprint on telecommunication projects in Taiwan, South America and East Asia), Dong A Group (Power plant projects - corporate financing) and Lotte. In addition, Mr. Kim has been instrumental in introducing Walmart, Hugo Boss, Jaeger, Sizzler, DKNY, Outback Restaurant, Epson, Gymboree, Sanrio Japan and other international corporations into the Korea markets. Mr. Kim has overseen the international finance and M&A section at law firms where he has advised on the most appropriate acquisition structure among statutory mergers, forward mergers, reverse mergers, triangular mergers, reverse triangular mergers, stock acquisitions, asset purchases, tender offers and management takeovers. Mr. Kim also has over 10 years of experience in intellectual property law, including patent, trademark, copyright, trade secret, unfair competition and other related areas. He has been an IP counsel to Merck and Co., Johnson & Johnson, Pfizer, GlaxoSmithKline, Novartis, Abbott Laboratories, Bayer Healthcare and top 50 pharmas in the world. Mr. Kim is a graduate of University of Pennsylvania Law School, LLM, SJD (C), M&A, Corporate Financing, Investment. He completed Saïd Business School, University of Oxford, Oxford Entrepreneurship: Venture Finance Programme, Certificate, 2019 – 2020 and the Harvard University Business School, Entrepreneurs Essentials, Certificate, 2018 – 2019. After graduating from Yonsei University, Seoul, Korea and University of Pennsylvania Law School in Philadelphia.

Positions